COSO vs EMF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
COSO presents a stark contrast between deep value and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades significantly below its Graham Number ($32.95) and Intrinsic Value ($43.45), this discount is likely a reflection of poor earnings quality, evidenced by four consecutive quarterly misses. Strong top-line revenue growth is being offset by declining Q/Q EPS growth (-12.1%) and a bearish technical trend (10/100). Consequently, the valuation appeal is currently outweighed by fundamental instability.
EMF presents a compelling value opportunity, anchored by a stable Piotroski F-Score of 5/9 and a current price ($20.41) that sits significantly below both its Graham Number ($36.14) and Intrinsic Value ($99.12). The fund exhibits exceptional valuation metrics with a P/E of 6.07, far below the sector average, and a strong ROE of 20.84%. While revenue growth is currently negative (-13.30%), the massive surge in earnings growth (98.90%) and negligible debt (D/E 0.02) suggest high operational efficiency. Despite a bearish technical trend score, the fundamental disconnect between price and fair value provides a substantial margin of safety.
Compare Another Pair
Related Comparisons
COSO vs EMF: Head-to-Head Comparison
This page compares CoastalSouth Bancshares, Inc. (COSO) and Templeton Emerging Markets Fund (EMF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.